Skip to main content
SHINIL PHARMACEUTICAL CO., LTD. logo

SHINIL PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 012790 ISIN · KR7012790002 KO Manufacturing
Open in API
Filings indexed 198 across all filing types
Latest filing 2019-04-01 Annual Report
Country KR South Korea
Listing KO 012790

About SHINIL PHARMACEUTICAL CO., LTD.

https://shinilpharma.com/

SHINIL PHARMACEUTICAL CO., LTD. is a drug manufacturing company that develops, produces, and sells a diverse range of pharmaceutical products. The company's portfolio encompasses various therapeutic areas, including vitamins, mineral supplements, anti-inflammatory enzymes, antihistamines, appetite stimulants, and treatments for liver disease. Its product offerings also include topical medications such as gels and medicated plasters. The company serves both domestic and international markets.

Recent filings

Filing Released Lang Actions
사업보고서 (2018.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for Sinil Pharmaceutical Co., Ltd. for the fiscal year 2018 (42nd period). It contains comprehensive financial data, management discussion, business operations, and governance information, which corresponds to the standard format of an Annual Report (10-K) in the Korean regulatory filing system (DART). FY 2018
2019-04-01 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of a General Meeting of Shareholders (AGM) for Shinil Pharmaceutical. It details the outcomes of voting on agenda items such as financial statement approval, dividend declarations, and the appointment of auditors. This aligns perfectly with the definition of a Declaration of Voting Results (DVA).
2019-03-26 Korean
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a regulatory filing from Shinil Pharmaceutical titled 'Audit Report Submission' (감사보고서 제출). It provides the audit opinion (unqualified/proper), key financial data (assets, liabilities, revenue, profit), and the name of the accounting firm. While it contains financial data, it is a formal notification of the submission of the audit report to the regulatory body (KRX), which fits the definition of an Audit Report/Information filing (AR). FY 2018
2019-03-15 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Sinil Pharmaceutical Co., Ltd. It contains the agenda for the upcoming Annual General Meeting (AGM), including financial statement approval, director/auditor appointments, and proposed amendments to the articles of incorporation. It also includes detailed financial statements (balance sheet, income statement, etc.) as supporting information for the shareholders. This type of document is standard for proxy solicitation and providing information to shareholders prior to an AGM, which falls under the Proxy Solicitation & Information Statement category.
2019-03-11 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Shinil Pharmaceutical. It outlines the date, location, and agenda items (financial statements, director/auditor appointments, and remuneration limits). This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of upcoming voting items, which falls under the Proxy Solicitation & Information Statement category.
2019-03-05 Korean
주주총회집중일개최사유신고
AGM Information Classification · 95% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) regarding the 'Reason for holding a General Meeting of Shareholders on a concentrated date'. It explains why the company, Shinil Pharmaceutical, is holding its meeting on a date that coincides with the 'concentrated' period identified by the KOSDAQ Association. Since this is a specific regulatory disclosure regarding meeting logistics and compliance with corporate governance guidelines rather than the meeting materials themselves or a report publication announcement, it falls under the general regulatory filing category.
2019-03-05 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.